FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Erythromycin Ethylsuccinate Powder for Suspension
Status: Discontinuation
»Therapeutic Categories: Anti-Infective

Expand all

Endo Pharmaceuticals, Inc. (New 02/08/2021)

Company Contact Information:
800-828-9393 option 5, then option 2

Presentation Posting Date Related Information
200 mg/5 mL (NDC 0254-1020-47) 02/08/2021
400 mg/5 mL (NDC 0254-1021-47) 02/08/2021

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English